Disclosures for "Hypoxia Affects Glymphatic Efficiency: Assessing Glymphatic Disruption in Obstructive Sleep Apnea Using Near-infrared Spectroscopy"
-
Author has nothing to disclose
-
Dr. Werner has received personal compensation for serving as an employee of Cogentis Therapeutics. Dr. Werner has stock in Cogentis Therapeutics. Dr. Werner has received intellectual property interests from a discovery or technology relating to health care. Dr. Werner has received intellectual property interests from a discovery or technology relating to health care. Dr. Werner has received personal compensation in the range of $100,000-$499,999 for serving as a Neurologist with United States Navy. Dr. Werner has received personal compensation in the range of $50,000-$99,999 for serving as a CEO / CoFounder with Cogentis Therapeutics.
-
Dr. Coon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arena Labs.
-
Dr. Amyot has nothing to disclose.
-
Dr. Pollatou has nothing to disclose.
-
Author has nothing to disclose
-
Ms. Metzger has received personal compensation for serving as an employee of The Geneva Foundation. Ms. Metzger has received research support from University of Michigan .